Clinical trials
ARDS (Moderate or Severe) clinical trials
Below are recruiting ards (moderate or severe) clinical trials, each written for real people, not researchers. We’re tracking 1,471 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07516444Recruiting
Tricuspid valve replacement using a new catheter device
This trial tests a new device that replaces a leaky tricuspid valve (a heart valve) without open-heart surgery. If your tricuspid valve isn't working well and medicines haven't helped enough, this procedure might improve your heart function and symptoms.
Minneapolis, MinnesotaAges 18 years+ - NCT07521280Recruiting
Personalized rehabilitation for knee or heel pain in young athletes
This study tests a personalized exercise program for teenagers with knee or heel pain caused by growth-related conditions like Osgood-Schlatter or Sever's disease. The program aims to reduce pain and help you get back to sports safely.
Gdansk, Debinki 7Ages 10–17 - NCT06696638Recruiting
Guiding breathing help with lung imaging vs. pressure in ARDS
This trial compares two ways to set the breathing machine for people with ARDS (a serious lung injury). One method uses a special imaging belt (EIT) to see how the lungs are working, while the other uses pressure measurements. The goal is to find the best way to adjust ventilator support to help you breathe more easily.
Wuhan, HubeiAges 18 years+ - NCT07511361RecruitingPhase 2
Tonlamarsen for high blood pressure after hospitalization
This study tests an investigational medication (Tonlamarsen) for people who were recently hospitalized for a very severe high blood pressure episode and also have heart or kidney disease. It aims to see if the drug can help control blood pressure after discharge.
Arvada, ColoradoAges 18 years+ - NCT07512167Recruiting
Predicting tetanus survival outcomes using severity scores
This study helps doctors better predict which tetanus patients are at highest risk of dying in the hospital. Researchers will use special scoring systems to identify the most severe cases early so treatment can be adjusted.
Cairo, Cairo GovernorateAges 18 years+ - NCT07501533RecruitingPhase 2
Insulin timing for severe stroke patients with high blood sugar
This study compares giving insulin early versus waiting a bit to lower blood sugar after a severe stroke. It may help understand the best timing to treat high blood sugar in this situation.
Wuhu, AnhuiAges 18 years+ - NCT06741137Recruiting
Inhaled nitric oxide and prone positioning for ARDS
This trial is testing whether adding inhaled nitric oxide to lying on your stomach (prone position) can help people with severe lung failure (ARDS) who are on a ventilator. It uses a special monitor (EIT) to check lung function in real time.
Yangzhou, JiangsuAges 18–80 - NCT07479758Recruiting
Brain scans and vision tests for severe mental illness
This study uses advanced MRI scans and visual perception tests to learn more about severe mental disorders like depression, schizophrenia, and bipolar disorder. It aims to improve diagnosis and treatment outcomes.
Hangzhou, ZhejiangAges 18–45 - NCT07469371Recruiting
CT-FFR guided heart treatment for severe aortic stenosis
This trial tests whether using a special CT scan (CT-FFR) to guide treatment improves outcomes for people with severe aortic stenosis (a narrowed heart valve). It may help doctors decide between valve replacement surgery or a less invasive procedure.
Kunming, YunnanAges 18 years+ - NCT06790875Recruiting
Comparing two ventilator settings for lung health in ARDS
This study tests two methods of adjusting a ventilator to see which one may better protect the lungs of patients with ARDS. It will help doctors learn how to set the machine to reduce strain on the lungs.
Wuhan, HubeiAges 18–80 - NCT07457125RecruitingPhase 1/Phase 2
Exosome therapy for mild to moderate Alzheimer's disease
This trial tests a new drug made from stem cell exosomes (CB-Exo-A600) to see if it can help people with mild to moderate Alzheimer's disease. It aims to slow down symptoms and improve quality of life.
BeijingAges 50 years+ - NCT07446517Recruiting
Laser therapy for knee or heel pain in young athletes
This study tests if low-level laser therapy can help teenagers with Osgood-Schlatter knee pain or Sever heel pain. It aims to reduce pain from sports, so you can keep playing.
Gdansk, PomeranianAges 10–17 - NCT07448675Enrolling by invitation
Thinking and memory in untreated severe mental illness
This study looks at how severe mental illness affects thinking and memory in people who have never been treated. It may help researchers understand the early brain changes and find better ways to help.
TianjinAges 18–65 - NCT07449572RecruitingPhase 1
Safety study of HT31-1 for healthy volunteers
This trial tests a new drug called HT31-1 to see if it's safe in healthy people. It looks at how the drug moves in your body and if it causes side effects. This is a first step before testing it in patients with ARDS (a serious lung condition).
Richmond, VirginiaAges 18–65 - NCT06805409Recruiting
Ultrasound test for kidney risk in ARDS patients
This study tests whether a special ultrasound of the veins (VExUS) can help predict kidney injury in people with severe breathing problems who are on a breathing machine and receiving medicine to support their blood pressure.
Créteil, Val de MarneAges 18–100 - NCT06681545Recruiting
Living with severe asthma as a young adult
This study explores what it's like to live with severe asthma as a young adult. It uses interviews or focus groups to understand your experiences, to help improve care for others like you.
Manchester, GreaterAges 16–25 - NCT06789380Recruiting
Generalist vs specialist care for severe personality disorders
This trial compares two types of treatment—generalist care by a therapist or specialist care—for people with severe personality disorders. It aims to find which approach works better and is more cost-effective.
Halsteren, North BrabantAges 18 years+ - NCT06751836Recruiting
New ways to treat severe dengue
This trial tests new strategies to treat dengue, ranging from mild to severe cases. It may help people with different stages of dengue find better care and support.
Guatemala CityAges 18 years+ - NCT07414342Recruiting
Study of RENATUS® valve for severe aortic stenosis
This study tests a new device called the RENATUS® Transcatheter Aortic Valve System for people with severe aortic stenosis. It is designed to replace the narrowed valve without open-heart surgery, and aims to see if it is safe and effective for patients with various surgical risk levels.
BeijingAges 60–100 - NCT07363642RecruitingPhase 3
Tezepelumab for severe asthma
This study tests a drug called tezepelumab for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this drug can reduce asthma attacks and improve symptoms.
BeijingAges 12–80 - NCT07368608RecruitingPhase 1/Phase 2
Testing a new drug for high blood pressure and cholesterol
This study tests a new medicine called BEBT-701 for people with mild to moderate high blood pressure and high cholesterol. The goal is to see if it can lower both blood pressure and LDL ('bad') cholesterol safely.
Changsha, HunanAges 18–60 - NCT07359846RecruitingPhase 3
Add-on treatment for severe uncontrolled asthma
This study tests a new add-on medicine called GB-0895 for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this medicine can reduce asthma attacks and improve breathing.
Bakersfield, CaliforniaAges 12–80 - NCT07359105Recruiting
Statin vs. LDL Goal Therapy for Older Adults with Diabetes
This trial compares two approaches to lower cholesterol in people aged 70+ with type 2 diabetes: a moderate statin dose versus adjusting treatment to reach a personalized LDL-C target. It aims to find which strategy better prevents heart problems.
SeoulAges 70 years+ - NCT07343960RecruitingPhase 1
Study of Capivasertib in people with moderate liver impairment
This trial tests how the drug capivasertib is processed by the body and how safe it is in people with moderate liver impairment. It aims to find the right dose for patients whose liver function is reduced but stable.
Rialto, CaliforniaAges 18–80
Hear when a new ARDS (Moderate or Severe) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ards (moderate or severe)?
- Yes. Clin2 currently lists 1,471 recruiting ards (moderate or severe) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ards (moderate or severe) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ards (moderate or severe) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.